Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Peer Christiansen"'
Autor:
Peer Christiansen, Lars Rolighed, Leif Mosekilde, Tanja Sikjaer, Peter Vestergaard, Lene Heickendorff, Lars Rejnmark
Publikováno v:
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2015, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', European Journal of Endocrinology, vol. 172, no. 5, pp. 609-617 . https://doi.org/10.1530/EJE-14-0940
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', Bone Abstracts, vol. 3, PP210 . https://doi.org/10.1530/boneabs.3.PP210
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2015, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', European Journal of Endocrinology, vol. 172, no. 5, pp. 609-17 . https://doi.org/10.1530/EJE-14-0940
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', Bone Abstracts, vol. 3, PP210 . https://doi.org/10.1530/boneabs.3.PP210
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2015, ' No beneficial effects of vitamin D supplementation on muscle function or quality of life in primary hyperparathyroidism : results from a randomized controlled trial ', European Journal of Endocrinology, vol. 172, no. 5, pp. 609-17 . https://doi.org/10.1530/EJE-14-0940
ContextImpairments of muscle function and strength in patients with primary hyperparathyroidism (PHPT) are rarely addressed, although decreased muscle function may contribute to increased fracture risk.ObjectiveWe aimed to assess the changes in muscl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb67bdca42b3bacd816cb3f1020352b
https://vbn.aau.dk/da/publications/ba201401-ed6b-4c5f-8eac-4ea23a3958f7
https://vbn.aau.dk/da/publications/ba201401-ed6b-4c5f-8eac-4ea23a3958f7
Autor:
P. Vestergaard, F. Melsen, Lene Heickendorff, Bjarke Moosgaard, Lis Mosekilde, Peer Christiansen
Publikováno v:
Moosgaard, B, Vestergaard, P, Heickendorff, L, Melsen, F, Christiansen, P & Mosekilde, L 2005, ' Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism ', Clinical Endocrinology, no. 63, pp. 506-513 .
Moosgaard, B, Vestergaard, P, Heickendorff, L, Melsen, F, Christiansen, P & Mosekilde, L 2005, ' Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism ', Clinical Endocrinology, vol. 63, no. 5, pp. 506-513 . https://doi.org/10.1111/j.1365-2265.2005.02371.x
Moosgaard, B, Vestergaard, P, Heickendorff, L, Melsen, F, Christiansen, P & Mosekilde, L 2005, ' Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism ', Clinical Endocrinology, vol. 63, no. 5, pp. 506-513 . https://doi.org/10.1111/j.1365-2265.2005.02371.x
Background: Primary hyperparathyroidism (PHPT) and vitamin D insufficiency are common conditions that can occur in combination. However, low plasma 25-hydroxyvitamin D (25OHD) may also enhance the risk of PHPT or modify disease severity. Aim: To comp
Autor:
Leif Mosekilde, Peter Vestergaard, Mogens Blichert-Toft, Peer Christiansen, Charlotte L. Mollerup, Vibe G. Frokjaer
Publikováno v:
Vestergaard, P, Mollerup, C L, Frøkjær, V G, Christiansen, P, Blichert-Toft, M & Mosekilde, L 2003, ' Cardiovascular events before and after surgery for primary hyperparathyroidism ', World J Surg, vol. 27, pp. 216-222 .
Vestergaard, P, Mollerup, C L, Frokjaer, V G, Christiansen, P M C, Blichert-Toft, M & Mosekilde, L 2003, ' Cardiovascular events before and after surgery for primary hyperparathyroidism ', World J Surg, vol. 27, no. 2, pp. 216-222 .
Vestergaard, P, Mollerup, C L, Frokjaer, V G, Christiansen, P M C, Blichert-Toft, M & Mosekilde, L 2003, ' Cardiovascular events before and after surgery for primary hyperparathyroidism ', World J Surg, vol. 27, no. 2, pp. 216-222 .
Cardiovascular disease (atherosclerosis and subsequent myo- cardial infarction (MI)) has been associated with primary hyperparathy- roidism. We aimed at studying cardiovascular events before and after sur- gery and mortality after surgery for primary
Publikováno v:
Rolighed, L, Rejnmark, L & Christiansen, P M 2013, ' Bone involvement in primary hyperparathyroidism and changes after parathyroidectomy ', U S Endocrinology, vol. 9, no. 2 .
Parathyroid hormone (PTH) is produced and secreted by the parathyroid glands and has primary effects on kidney and bone. During the pathological growth of one or more parathyroid glands, the plasma level of PTH increases and causes primary hyperparat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96335ce86d84cfb0f21411f1f3f51bfd
https://europepmc.org/articles/PMC5983103/
https://europepmc.org/articles/PMC5983103/
Autor:
Lars Rolighed, Peer Christiansen, Tanja Sikjaer, Lars Rejnmark, Lene Heickendorff, Leif Mosekilde, Peter Vestergaard
Publikováno v:
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' Vitamin D Treatment in Primary Hyperparathyroidism : A Randomized Placebo Controlled Trial ', Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 3, jc20133978, pp. 1072-1080 . https://doi.org/10.1210/jc.2013-3978
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' Vitamin D Treatment in Primary Hyperparathyroidism : a Randomized Placebo Controlled Trial ', Journal of Clinical Endocrinology and Metabolism, pp. jc20133978 . https://doi.org/10.1210/jc.2013-3978
Rolighed, L, Rejnmark, L, Sikjær, T T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P M 2013, ' Vitamin D Treatment in Primary Hyperparathyroidism : A Randomized Placebo Controlled Trial ', Journal of Bone and Mineral Research, vol. 28, no. Suppl. 1, SU0182 .
Rolighed, L, Rejnmark, L, Sikjaer, T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P 2014, ' Vitamin D Treatment in Primary Hyperparathyroidism : a Randomized Placebo Controlled Trial ', Journal of Clinical Endocrinology and Metabolism, pp. jc20133978 . https://doi.org/10.1210/jc.2013-3978
Rolighed, L, Rejnmark, L, Sikjær, T T, Heickendorff, L, Vestergaard, P, Mosekilde, L & Christiansen, P M 2013, ' Vitamin D Treatment in Primary Hyperparathyroidism : A Randomized Placebo Controlled Trial ', Journal of Bone and Mineral Research, vol. 28, no. Suppl. 1, SU0182 .
Low 25-hydroxyvitamin D levels are common in patients with primary hyperparathyroidism (PHPT) and associated with higher PTH levels and hungry bone syndrome after parathyroidectomy (PTX). However, concerns have been raised about the safety of vitamin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bac43c66e28bf00be48c14c968540d9
https://vbn.aau.dk/da/publications/ab4b6166-881a-4277-afb2-d70ddaf16c06
https://vbn.aau.dk/da/publications/ab4b6166-881a-4277-afb2-d70ddaf16c06
Autor:
Lars Rejnmark, Niels Frederik Breum Jakobsen, Lars Rolighed, Leif Mosekilde, Peer Christiansen, Anne Kristine Amstrup, Tanja Sikjaer
Publikováno v:
Rolighed, L, Amstrup, A K, Jakobsen, N F B, Sikjaer, T, Mosekilde, L, Christiansen, P & Rejnmark, L 2013, ' Muscle Function Is Impaired in Patients With "Asymptomatic" Primary Hyperparathyroidism ', World Journal of Surgery, vol. 38, no. 3, pp. 549-557 . https://doi.org/10.1007/s00268-013-2273-5
Patients with “asymptomatic” primary hyperparathyroidism (PHPT) often describe improvement after surgery. We evaluated muscle and balance function, quality of life (QoL), and well-being in 58 PHPT patients and 58 population-based matched controls
Autor:
Charlotte L. Mollerup, Vibe G. Frokjaer, Peer Christiansen, Peter Vestergaard, Mogens Blichert-Toft, Leif Mosekilde
Publikováno v:
BMJ. 321:598-602
Objectives: To study whether fracture risk before and after surgery was increased in patients with primary hyperparathyroidism. Design: Cohort study. Setting: Three Danish university hospitals. Participants: 674 consecutive patients with primary hype
Autor:
F. Melsen, Le. Mosekilde, R. Ullerup, Ib Hessov, Peer Christiansen, Torben Steiniche, A. Vesterby
Publikováno v:
Bone. 26:535-543
In 19 patients with primary hyperparathyroidism (PHPT) (14 women and 5 men; age 53 +/- 11 years, range 29-69 years), bone densitometry, biochemical markers of bone turnover, and iliac crest bone biopsies were obtained before and 3 years after success
Publikováno v:
World Journal of Surgery. 24:102-107
The purpose of this study was to evaluate changes in muscular strength and endurance, work capacity, and subjective fatigue following surgical treatment of primary hyperparathyroidism (pHPT), and to assess whether changes in muscular function were du
Autor:
Lars Rolighed, Lars Rejnmark, Leif Mosekilde, Tanja Sikjaer, Niels Frederik Breum Jakobsen, Peer Christiansen, Anne Kristine Amstrup
Publikováno v:
Rolighed, L, Amstrup, A K, Frederik Breum Jakobsen, N, Sikjaer, T, Mosekilde, L, Christiansen, P & Rejnmark, L 2013, ' Muscle function and Quality of Life in Primary Hyperparathyroidism ', Lisbon, Portugal, 18/05/2013-21/05/2013, .
Aarhus University
Aarhus University